Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

The shortages were declared in August 2022. Meanwhile, Axios reports on how makers of copycat weight loss drugs are preparing for a crackdown. In medical tech and pharma news: a pacemaker recall, the ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Nicole started Wegovy when she was unable to obtain Ozempic amid the shortage of the drug, which is used for diabetes. But the 51-year-old has also experienced a plateau in weight loss.

Wegovy is the first GLP-1 medication for weight loss to gain approval from the Food and Drug Administration (FDA). The organization approved it in 2021. However, there are strict eligibility ...

Vials of Wegovy at a Novo Nordisk production line in Hillerod, Denmark. The company argues government subsidies for its weight-loss drugs will help Australia tackle obesity. Bloomberg “Novo ...

Since then, Wegovy has been shown to decrease ... Critics argue the number of people taking a GLP-1 for weight loss has led to a shortage of the drug for people with diabetes.

Hims & Hers offers compounded versions of the weight-loss drug semaglutide, which was developed by Novo Nordisk and is typically sold under the names Wegovy and Ozempic. The Partnership for Safe ...